| Patent application number | Description | Published |
|---|
| 20080214635 | Modulation of pathogenicity - The present invention relates to the use of compounds of the general Formula (I): | 09-04-2008 |
| 20080261971 | Novel Heterocyclic Nf-Kb Inhibitors - The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, (I) wherein R | 10-23-2008 |
| 20090042904 | Substituted Phenly-Piperazine Compounds, Their Preparation And Use In Medicaments - The present invention relates to substituted phenyl-piperazine compounds of general formula (I), a process for their preparation, medicaments comprising said substituted phenyl-piperazine compounds as well as the use of said substituted phenyl-piperazine compounds for the preparation of medicaments, which are particularly suitable for the prophylaxis and/or treatment of disorders or diseases that are at least partially mediated via 5-HT | 02-12-2009 |
| 20090076012 | Modulation of pathogenicity - The present invention relates to the use of compounds of the general Formula (I): | 03-19-2009 |
| 20090192192 | INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA - The present invention relates to the use of compounds as broad spectrum inhibitors of bacterial biofilm formation. In particular the invention refers to a family of compounds that block the quorum sensing system of Gram-negative and Gram-positive bacteria, a process for their manufacture, pharmaceutical compositions containing them and to their use for the treatment and prevention of bacterial damages and diseases, in particular for diseases where there is an advantage in inhibiting quorum sensing regulated phenotypes of pathogens. | 07-30-2009 |
| 20100004258 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates to compounds of the general formula (III): | 01-07-2010 |
| 20100048574 | NOVEL HETEROCYCLIC NF-kB INHIBITORS - The present invention relates to compounds of the general formula (II): | 02-25-2010 |
| 20100048583 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, | 02-25-2010 |
| 20100267717 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates in one embodiment to compounds of formula (Ih) and/or a pharmaceutically acceptable salt thereof with an acid or a base, and/or a pharmaceutically acceptable prodrug and/or a stereoisomer thereof, | 10-21-2010 |
| 20100280034 | Modulation of pathogenicity - The present invention relates to the use of compounds of the general Formula (XIII): | 11-04-2010 |
| 20100280036 | Modulation of Pathogenicity - The present invention relates to the use of compounds of the general Formula (I): | 11-04-2010 |
| 20110105597 | Modulation of pathogenicity - The present invention relates to the use of compounds of the general Formula (I): | 05-05-2011 |
